Semler Research Centre Private Ltd (SRC), a contract research organisation, today opened a $10-million centre for scientific study of drug and their evaluation.
The company said it aims to double its investment in the centre in next three years.
"The expansion will give SRC an opportunity to unite the world of pharmaceutical research across the globe and enable us to complete the loop in the drug development cycle," SRC President Krathish Bopanna said.
It will provide easy access to facilities for an early stage research in India, he said.
The new facility is spread over 25,000 square feet and is equipped with three clinical pharmacology units with an 80 bed capacity.
The company also plans to increase its head count from 134 to 300 by the end of the fiscal, he said.
It was also looking at acquisitions in the US in the biometric space and was in talks with two firms.
"As a company we envisage enormous potential in the biometric space where we hope to delve further through inorganic growth strategies," he said.
The company currently has a formulation development centre in Bangalore.